ARCHIVES

BioSeek Awarded NIH SBIR For Compound Validation.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

Sales of Smoking Cessation Aids Increase, Effectiveness Drops

October 25, 2002

AACR settles dispute with Toronto Convention Center and hotels over cancellation of 2003 annual meeting. Travelers Insurance covered AACR’s claim.

April 15, 2005

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

In Brief: UICC Honors Dodd; Centers Recognize Nealon; Tale Expands Transplant Program

March 28, 1997

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001